Preventable Adverse Drug Reaction in pharmacovigilance database

Similar documents
PHARMACOVIGILANCE RESEARCH APPLIED IN PROMOTION OF RATIONAL AND SAFE USE OF MEDICINES: EXPERIENCE FROM RESOURCE LIMITED SITUATION IN VIETNAM

A Retrospective Cross- sectional Study Evaluating Beta- lactam Allergy Labeling in Hospitalized Patients

Drug Allergy A Guide to Diagnosis and Management

Non-Beta-lactam Antibiotic: Testing and Desensitization

Allergy Status Identification And Documentation

Medical Documentation/Records. ADVERSE DRUG REACTIONS (ADRs) AND ALLERGIES TO MEDICATIONS

Inpatient Beta-lactam Allergy Guideline

Product Information BROWN SNAKE ANTIVENOM AUST R 74897

This letter authorises the extended use of the following guidance until 1st December 2018:

TARGETED SPONTANEOUS REPORTING FOR ADVERSE EVENTS RELATED TO ARV:

Annex I: Proposed Core Safety Profile (CSP) 4.3 Contraindications

Sources of ADRs - Recorded from in Tamil Nadu State, India

LEMTRADA REMS Education Program for Healthcare Facilities

ANAPHYLAXIS IN ANESTHESIA

THE NON PENICILLIN BETA LACTAM DRUG CROSS CONTAMINATION PREVENTION; USFDA PERSPECTIVE

Multiple Drug Allergies

Anaphylaxis: clinical features, management and avoidance

Responders as percent of overall members in each category: Practice: Adult 537 (51% of 1063 members) 23 (59% of 39 members)

Determination of Incidence and Characteristics of Preventable Adverse Drug Reactions : A Study in Phrae Hospital

MB Guideline 7. Transfusion Reaction- Identification, Management and Reporting

TITLE: SAFE USE OF MEDICINES IN ZANZIBAR A

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vancomycin Mylan 1000 mg, powder for concentrate for solution for infusion. Vancomycin

Vancomycin Orion , Version 2 Public Summary of the Risk Management Plan

Contributes to CQC Outcome number: 9&12 Consulted With Post/Committee/Group Date. Pharmacist. Alison Felton Head of Pharmacy/Deputy Chief.

December 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide

Beta-Lactam Use in Penicillin Allergic Patients Clinical Guideline

Finish the course for as little as $ Start the course for as little as

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 9 May 2012

2015 VIETNAMESE AMERICAN MEDICAL ASSOCIATION (VAMA) CONVENTION WASHINGTON, D.C MEDICAL, DENTAL, AND PHARMACY

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

BRIEF: Why are we making these changes?

Shirin Abadi, B.Sc.(Pharm.), ACPR, Pharm.D. Clinical Pharmacy Specialist & Pharmacy Education Coordinator, BC Cancer Agency Clinical Associate

CAUTION: You must refer to the intranet for the most recent version of this procedural document.

A Case Report on Paracetamol Induced Generalized Fixed Drug Eruptions

Policy for the use of intravenous Iron Dextran (CosmoFer )

LEEDS TEACHING HOSPITALS TRUST

Antimicrobial Management of Febrile Neutropenic Sepsis

Adverse Events Monitoring (aka Pharmacovigilance)

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Lecture 03: Drug allergy

Penicillin Allergy and Use of Other Antibiotics

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients)

jpc.tums.ac.ir Pharmacist, Pharmaceutical Care Department of Emam Khomeini Hospital, Sari, Mazandaran, Iran

Diagnosis and management of suspected drug allergies

Copy of the mail received from the Vietnamese company

Antibiotic allergy in the Intensive Care. Sanjay Swaminathan Clinical Immunologist, Westmead and Blacktown Hospitals September 28, 2017

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control

The Yellow Card scheme why are GPs under-reporting?

METHYLENE BLUE-TREATED FRESH FROZEN PLASMA AND RELATED ADVERSE REACTIONS IN FRANCE: THE LONGER THE EXPERIENCE THE MORE ROBUST THE RESULTS

Guidance for Industry

Methodological Framework and Tools for Cross-National comparisons of Drug Utilization Data

Carboplatin / Liposomal Doxorubicin CARBO/CAELYX Gynaecological Cancer

Sign up to receive ATOTW weekly -

Summary of adverse drug reaction reports in Sweden with Pandemrix (received up to...

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS

Session 2. Data analysis based on overview of EudraVigilance data. Victoria Newbould, EMA, EU. Medication-errors workshop London, 20 October 2016

Billing and Coding Information

UNIVERSITI KEBANGSAAN MALAYSIA Published by Universiti Kebangsaan Malaysia (UKM)

Review of OTC Cough and Cold Medicines

Dispensing Operation Analysis of Herbal Medicine in Khanh Hoa Traditional Medicine and Rehabilitation Hospital

Vancomycin Orion , Version 1.0. Public Summary of the Risk Management Plan

Incidence and Severity of Adverse Drug Reactions and Spontaneous Adverse Drug Reporting in Hospital Settings of Lahore

Title: Cutaneous Adverse Drug Reactions in Indian population: A systematic review

Annual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2016

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

Results and discussion 1. The density of rice planthopper in Northern Viet Nam in the recent year. Table 1: Hybrid rice areas in Northern Viet Nam

The mechanisms of common drug hypersensitivities and implications for testing

Soliris (eculizumab): Paroxysmal nocturnal haemoglobinuria (PNH) Patient/Parent information brochure

A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity

Transfusion Reactions

New product information wording Extracts from PRAC recommendations on signals

PRAC recommendations on signals

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)

Medication Errors a challenge of pharmacovigilance BfArM experience

Management of an immediate adverse event following immunisation

Original Article Mahidol Univ J Pharm Sci 2015; 42 (4), MT. Nguyen 1, TD. Dang Nguyen 1* 1

PART VI. SUMMARY OF THE RISK MANAGEMENT PLAN Summary of risk management plan for ZINFORO

ROSOBAC-1GM / ROSOBAC-FORT

Patient Group Direction for the supply and/or administration of Ibuprofen 400mg tablets to patients attending NHS Borders services

2014 Midyear Clinical Meeting No Hives About It: An Evidence-Based Approach to Managing Patients with a History of Drug Allergies

Adverse Drug Reactions (ADRs) Outline

Therapeutic drug monitoring of β-lactams

DALES Anaesthetist Survey

Penicillin Allergy Edition December 11 th, 2018

Supplementary Online Content

Administering epinephrine for acute anaphylactic type allergic reactions

02/06/2013. Goal of program. A few definitions. Objectives of the training. Legal context. Legal context in schools

PM-03 PED ALLERGY/ANAPHYLAXIS. Protocol SECTION: PM-03 PROTOCOL TITLE: PED ALLERGY/ANAPHYLAXIS REVISED: 01MAY2018

Paclitaxel Gastric Cancer

Anaphylaxis/Latex Allergy

Vancomycin Drug Class 1

by author ESCMID Online Lecture Library Steroids in acute bacterial meningitis

Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine

Adverse drug reactions

Intervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist

Acute urticaria in children - management. Clive Grattan St John s Institute of Dermatology, London Norfolk & Norwich University Hospital

Durvalumab (previously known as MEDI 4736) Maintenance (Arm A3) PLATFORM study

Urticaria and Angioedema. Allergy and Immunology Awareness Program

Annex I SCIENTIFIC CONCLUSIONS AND GROUNDS FOR THE VARIATION TO THE TERMS OF THE MARKETING AUTHORISATION(S)

Drug utilization evaluation of cephaosporins in a tertiary care hospital: inpatient departments.

Transcription:

Preventable Adverse Drug Reaction in pharmacovigilance database Vu Dinh Hoa National Drug Information and Adverse Drug Monitoring Center Hanoi University of Pharmacy Vietnam 1

Introductions Until 2017: 66000 reports in the database ADE ADR Medication errors Preventable ADR ADE: Adverse drug event ADR: Adverse drug reaction Low quality/counterfei t drugs Fig. 4 Number of ADR reports in Vietnamese database. SIDCA Swedish International Development Cooperation Agency, DAV Drug Administration of Vietnam, NPVC National Pharmacovigilance center, ADR Adverse Drug Reaction Nguyen KD et al. Drug Saf. 2018 Feb;41(2):151-159 Preventable Adverse Drug Reaction in pharmacovigilance database 2

Methods Preventability accessment form Spontaneous ADR reports: 1546 Causal relationship: 3203 drug-event pairs/1508 report certain, probably, possibly Preventable/Partly preventable ADR: 132 Causality assessment: WHO criteria, routine process in NPVC Preventability assessment: French method: Imbs (1998), Olivier (2005) [1] 1. Therapie. 2005 Jan-Feb;60(1):39-45 Level Preventability Score 1 Preventable -13 to -8 or ME 2 Partly preventable -7 to -3 3 Not assessable -2 to +2 4 Not preventable +3 to +8 Preventable Adverse Drug Reaction in pharmacovigilance database 3

Results Patient information N (%) Female (n, %) 65 (49.2) Age (years) 42.3 ± 21.3 Weight (kg) 50.5 ± 15.5 Health care staff s occupation Patient characteristic and the most common padr (n=132) Pharmacists 71 (53.8) Doctors 25 (18.9) Others (Nurses. midwives ) 30 (22.7) Pharmacist played important role Type B ADR are common Most common padr N (%) Pruritus 34 (25.8) Rash erythematous 33 (25.0) Anaphylactic reaction/shock 24 (18.2) Rash 15 (11.4) Oedema eyelid 11 (8.3) Application site reaction 10 (7.6) Urticaria 10 (7.6) Fatigue 8 (6.1) Preventable Adverse Drug Reaction in pharmacovigilance database 4

Results Most common drugs/drug groups related to the padr (n=132) ATC code Drug groups N(%) J01D Other betalactams (*) 101 (76.5) J01M flouroquinolons 73 (55.3) J01C penicilines 22 (16.7) M01A NSAIDs 16 (12.1) J01X Other antibiotics (**) 10 (7.6) N02B Antipyretics and analgesocs (***) 9 (6.8) J04A Antituberculosis agents 6 (4.5) (*) cephalosporins, monobactams và carbapenems (**) glycopeptids, polymyxins, imidazols and others (***) acid salycilic and derivatives, pyrazolons, anilids and others Most common causal drugs N (%) Cefotaxim 7 (5.3) Ciprofloxacin 6 (4.5) Diclofenac 6 (4.5) Paracetamol (4.5) Moxifloxacin 6 (4.5) Amoxicilin/sulbactam 5 (3.8) Ceftazidim 5 (3.8) Cefoperazon 4 (3.0) Antimicrobial agents and NSAIDs Preventable Adverse Drug Reaction in pharmacovigilance database 5

Results Severity of the padr (N=132) Level Severity N (%) 1 Mild 21 (15.9) 2 Moderate 19 (14.4) 3 Severe 62 (47.0) 4 Life threatening 6 (4.5) 5 Fatal 1 (0.8) - Others (*) 23 (17.4) (**) Lack of information for CTCAE grading scale Preventable Adverse Drug Reaction in pharmacovigilance database 6

Results Suspect reason for padr (N=132) Drug use process Reason for error N (%) Involved person Dispensing Self medication 11 (8.3) Patients, Pharmacists Prescribing Allergic history/cross allergic 33 (25.5) Doctors Irrational indications Inappropriate dose 73 (55.3) 5 (3.8) Preparation Injection dilution errors 3 (2.3) Nurses Administration Inappropriated route Infusion rate error Wrong drug 4 (2.3) 2 (1.5) 1 (0.8) Nurses Preventable Adverse Drug Reaction in pharmacovigilance database 7

Results Case: Patient aged 89, surgery prophylaxis by UNASYN (ampiciline + sulbactam) 1.5g Anaphylactic shock after 4 min: dyspnea; 80/50 mmhg, tachycardia, cold extremities. Patient died even after being treated according to the standard anaphylaxis shock guideline. Penicillin allergic history Historical allergy to penicillin Preventable Adverse Drug Reaction in pharmacovigilance database 8

Conclusion Determining the preventability (or ME) is possible from spontaneous ADR reports. The padr reflect drug use behavious: cutaneous reactions were common, related to antibiotics/nsaids (most common used drug). Common reasons to define preventability: self medication, used historical allergic drug, irrational indication and dose, wrong dilution, wrong route, wrong infusion rate, wrong drug. Preventable Adverse Drug Reaction in pharmacovigilance database 9

THANK YOU!! Tran Thi Khanh Ngan (Msc. Student) Tran Ngan Ha (Msc.) Duong Khanh Linh (Msc.) Vu Dinh Hoa (PhD.) Nguyen Hoang Anh (PhD.)